Compare Cronos Group Inc (CRON) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Moderna, Inc. — how do they compare? Cronos Group Inc trades at $3.08 (market cap $1.14B), while Moderna, Inc. trades at $60.61 (market cap $24.18B). The key difference: Moderna, Inc. is far larger — about 21.2× Cronos Group Inc's market cap, and Cronos Group Inc is trading nearer its 52-week high, Moderna, Inc. nearer its low. Which is the better fit depends on your goals.
| CRON | MRNA | |
|---|---|---|
Market Cap | $1.14B | $24.18B |
Sector | Health | Health |
52-Week High | $3.27 | $81.80 |
52-Week Low | $2.30 | $22.36 |
Enterprise Value | $341.13M | $20.33B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
